Ergoteles’s Enfusion, Inc. ENFN Stock Holding History

Ergoteles’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,260	Closed	-$227K	–	897
2023 Q2	$227K	Buy	+20,260	New	+$180K	0.01%	833
2022 Q4	–	Sell	-13,963	Closed	-$172K	–	1967
2022 Q3	$172K	Buy	13,963 +263	+2%	+$3.21K	0.01%	1235
2022 Q2	$140K	Buy	+13,700	New	+$151K	﹤0.01%	1438

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Ergoteles's ENFN Position: Q3 2023 in Review

Ergoteles sold out of Enfusion, Inc. (ENFN) in Q3 2023, closing a stake of 20,260 shares — an estimated $227K sold.

Ergoteles first reported a position in ENFN in Q2 2022 and held it in 3 quarters. The position peaked at $227K in Q2 2023. 75 funds tracked by Wall St. Rank hold ENFN as of Q3 2023.

Ergoteles reported no remaining Enfusion, Inc. position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 20,260 Enfusion, Inc. shares in Q3 2023, an estimated $227K.
Ergoteles first reported a position in Enfusion, Inc. in Q2 2022 and held it in 3 quarters.
Ergoteles's Enfusion, Inc. position peaked at $227K in Q2 2023.
75 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.